104997-24-2 Usage
Uses
Used in Chemical Synthesis:
(3-Phenoxy-Phenyl)-Hydrazine is used as a reagent or intermediate in the synthesis of complex chemicals, particularly in the field of chemistry. Its reactive hydrazine group enables it to undergo various organic reactions, making it a valuable component in the creation of new compounds and materials.
Used in Research and Development:
In the scientific community, (3-Phenoxy-Phenyl)-Hydrazine serves as a key component in research and development projects, where its unique properties and reactivity are harnessed to explore new chemical pathways and develop innovative applications.
Used in Pharmaceutical Industry:
(3-Phenoxy-Phenyl)-Hydrazine may be utilized as a building block in the development of pharmaceutical compounds, given its potential to form new chemical entities with therapeutic properties. However, due to the potential health risks associated with hydrazine derivatives, extensive research and safety assessments are necessary to ensure the safety and efficacy of any resulting pharmaceutical products.
Used in Material Science:
In the field of material science, (3-Phenoxy-Phenyl)-Hydrazine can be employed in the synthesis of novel materials with specific properties, such as conductivity, magnetism, or optical characteristics. Its reactivity and ability to form new compounds make it a promising candidate for the development of advanced materials with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 104997-24-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,9,9 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 104997-24:
(8*1)+(7*0)+(6*4)+(5*9)+(4*9)+(3*7)+(2*2)+(1*4)=142
142 % 10 = 2
So 104997-24-2 is a valid CAS Registry Number.
104997-24-2Relevant articles and documents
BETA-SECRETASE INHIBITING COMPOUNDS HAVING OXO-DIHYDRO-PYRAZOLE MOIETY
-
Page/Page column 31, (2009/04/25)
Disclosed are compounds represented by Formula (I) as defined in the specification, or pharmaceutically acceptable salts or isomers thereof, and a pharmaceutical composition for inhibiting beta-secretase activity comprising a therapeutically effective amo